Related Experiment Video
Updated: Jul 5, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
Protease-activated receptor-2 activation: a major actor in intestinal inflammation
E Hyun1, P Andrade-Gordon, M Steinhoff
1Department of Pharmacology and Therapeutics, University of Calgary, Calgary, Canada.
Background And Aims:
The role of protease-activated receptor-2 (PAR(2)) during intestinal inflammation is still unclear due to the fact that PAR(2)-activating peptide has both pro- and anti-inflammatory properties. The aim of this study was to investigate the effects of PAR(2) deficiency (using PAR(2)-deficient mice, PAR(2)(-/-)) in models of colitis, in order to elucidate the role of endogenous PAR(2) in the process of inflammation in the gut.
Methods:
Colonic inflammation in wild-type and PAR(2)(-/-) mice was induced by dextran sodium sulfate, trinitrobenzene sulfonic acid (TNBS), a T helper-1 predominant model, or oxazolone, a T helper-2 predominant model. Leukocyte recruitment, assessed by intravital microscopy, and inflammatory parameters (myeloperoxidase (MPO), macroscopic and microscopic damage) were assessed during the development of colitis. Lastly, the protein levels of cyclooxygenases (COXs) and adhesion molecules (ICAM-1, VCAM-1, alpha-M, alpha-4) were assessed by using western blot analysis.
Results:
In all three models of colitis, MPO activity, macroscopic damage score and bowel thickness were significantly lower in PAR(2)(-/-) mice. Changes in vessel leukocyte recruitment parameters (rolling and adhesion) were also significantly reduced in PAR(2)(-/-) mice compared to wild-type mice after the induction of colitis. The protein expression of ICAM-1, VCAM-1 and alpha-4 was significantly attenuated, whereas the expression of COX-1 was significantly increased in PAR(2)(-/-) mice challenged with TNBS-induced colitis.
Conclusions:
The role of endogenous PAR(2) in the gut is pro-inflammatory and independent of the T helper-1 or -2 cytokine profile. Endogenous PAR(2) activation controls leukocyte recruitment in the colon and thus appears as a new potential therapeutic target for the treatment of inflammatory bowel disease.
Insights
Protease-activated receptor-2 (PAR(2)) plays a pro-inflammatory role in gut inflammation. PAR(2) deficiency reduces inflammation and leukocyte recruitment, suggesting it as a therapeutic target for inflammatory bowel disease.
Area of Science:
- Gastroenterology
- Immunology
- Molecular Biology
Background:
- The role of protease-activated receptor-2 (PAR(2)) in intestinal inflammation is complex, with conflicting evidence regarding its pro- or anti-inflammatory effects.
- Investigating PAR(2) deficiency in mouse models is crucial to understand the function of endogenous PAR(2) in gut inflammation.
Purpose of the Study:
- To elucidate the role of endogenous PAR(2) in the development of colitis.
- To determine if PAR(2) deficiency impacts inflammatory responses in different models of intestinal inflammation.
Main Methods:
- Induction of colitis in wild-type and PAR(2)-deficient mice using dextran sodium sulfate, trinitrobenzene sulfonic acid (TNBS), or oxazolone.
- Assessment of leukocyte recruitment, myeloperoxidase (MPO) activity, and tissue damage.
- Analysis of cyclooxygenase (COX) and adhesion molecule (ICAM-1, VCAM-1, alpha-M, alpha-4) protein expression via western blot.
Main Results:
- PAR(2)-deficient mice exhibited significantly reduced MPO activity, macroscopic damage, and bowel thickness across all colitis models.
- Leukocyte rolling and adhesion in the colon were significantly decreased in PAR(2)-deficient mice.
- TNBS-induced colitis showed attenuated ICAM-1, VCAM-1, and alpha-4 expression, but increased COX-1 expression in PAR(2)-deficient mice.
Conclusions:
- Endogenous PAR(2) activation has a pro-inflammatory role in the gut, independent of T helper-1 or -2 profiles.
- PAR(2) controls leukocyte recruitment in the colon, identifying it as a potential therapeutic target for inflammatory bowel disease (IBD).
More Related Videos
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Regulation of the Unfolded Protein Response
Gastritis II: Pathophysiology
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...